{"id":21268,"date":"2026-06-09T07:28:38","date_gmt":"2026-06-09T07:28:38","guid":{"rendered":"https:\/\/www.neuraxpharm.com\/uk\/?page_id=21268"},"modified":"2026-06-09T07:31:01","modified_gmt":"2026-06-09T07:31:01","slug":"non-financial-information-statement","status":"publish","type":"page","link":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/non-financial-information-statement\/","title":{"rendered":"Non financial information statement"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-page\" data-elementor-id=\"21268\" class=\"elementor elementor-21268\" data-elementor-post-type=\"page\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-26b5ec2 elementor-section-full_width elementor-section-content-middle elementor-section-height-default elementor-section-height-default\" data-id=\"26b5ec2\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[],&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-f177c50\" data-id=\"f177c50\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-992bd5a elementor-widget elementor-widget-text-editor\" data-id=\"992bd5a\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"font-weight: 400; font-size: 16px !important;\">This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-7c17f5b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"7c17f5b\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-ffd716e\" data-id=\"ffd716e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-30392ca elementor-widget elementor-widget-text-editor\" data-id=\"30392ca\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>(Estado de Informaci\u00f3n No Financiera \u2013 EINF, in Spanish)<\/p><p>In order to comply with Law 11\/2018 on Non-Financial Information and Diversity, annually\u00a0 Neuraxpharm Pharmaceuticals S.L.U. (formerly Laboratorios Lesvi S.L.U.)\u00a0prepares its Non-Financial Information Statement, following the recommendations and indications established by the beforementioned 11\/2018 Law.<\/p><p>The report includes information on environmental, social and personnel issues, human rights, the fight against corruption and bribery, and the impact of the organisation on society. For each of the issues, it describes the policies and actions developed, as well as the risks identified and derived from the development of the company&#8217;s activity. The report has been prepared in accordance with the principles of comparability, reliability, materiality and relevance set out in the beforementioned 11\/2018 Law.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-b99f7ae elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"b99f7ae\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-81caa3e\" data-id=\"81caa3e\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-a7bbe44 elementor-widget elementor-widget-button\" data-id=\"a7bbe44\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2026\/06\/09072955\/informe-einf-neuraxpharm-pharmaceuticals-2023.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Non-Financial Information Report 2023<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-1a51cd7 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1a51cd7\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-3de8bff\" data-id=\"3de8bff\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0794ca3 elementor-widget elementor-widget-button\" data-id=\"0794ca3\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2026\/06\/09073002\/informe-einf-laboratorios-lesvi-2022.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Non-Financial Information Report 2022<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-inner-section elementor-element elementor-element-1d145ab elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"1d145ab\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[]}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-inner-column elementor-element elementor-element-cca4db8\" data-id=\"cca4db8\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-4d1351b elementor-widget elementor-widget-button\" data-id=\"4d1351b\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/static.neuraxpharm.com\/wp-content\/uploads\/sites\/19\/2026\/06\/09073007\/informe-einf-laboratorios-lesvi-2021.pdf\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t<span class=\"elementor-button-icon\">\n\t\t\t\t<i aria-hidden=\"true\" class=\"fas fa-download\"><\/i>\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Non-Financial Information Report 2021<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-f3e4c96 elementor-section-full_width elementor-section-content-middle elementor-section-height-default elementor-section-height-default\" data-id=\"f3e4c96\" data-element_type=\"section\" data-e-type=\"section\" data-settings=\"{&quot;jet_parallax_layout_list&quot;:[],&quot;background_background&quot;:&quot;classic&quot;}\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-197ff4c\" data-id=\"197ff4c\" data-element_type=\"column\" data-e-type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-8c96615 elementor-widget elementor-widget-text-editor\" data-id=\"8c96615\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p style=\"font-weight: 400; font-size: 16px !important;\">This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business (Estado de Informaci\u00f3n No Financiera \u2013 EINF, in Spanish) In order to comply with Law 11\/2018 on Non-Financial Information and Diversity, annually\u00a0 Neuraxpharm Pharmaceuticals S.L.U. (formerly Laboratorios Lesvi S.L.U.)\u00a0prepares its Non-Financial Information Statement, following the recommendations and [&hellip;]<\/p>\n","protected":false},"author":2493,"featured_media":0,"parent":2412,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"elementor_header_footer","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-21268","page","type-page","status-publish","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v27.2 (Yoast SEO v27.8) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>Non financial information statement - Neuraxpharm<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/non-financial-information-statement\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Non financial information statement\" \/>\n<meta property=\"og:description\" content=\"This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business (Estado de Informaci\u00f3n No Financiera \u2013 EINF, in Spanish) In order to comply with Law 11\/2018 on Non-Financial Information and Diversity, annually\u00a0 Neuraxpharm Pharmaceuticals S.L.U. (formerly Laboratorios Lesvi S.L.U.)\u00a0prepares its Non-Financial Information Statement, following the recommendations and [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/non-financial-information-statement\/\" \/>\n<meta property=\"og:site_name\" content=\"Neuraxpharm\" \/>\n<meta property=\"article:modified_time\" content=\"2026-06-09T07:31:01+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/about-us\\\/manufacturing\\\/non-financial-information-statement\\\/\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/about-us\\\/manufacturing\\\/non-financial-information-statement\\\/\",\"name\":\"Non financial information statement - Neuraxpharm\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/#website\"},\"datePublished\":\"2026-06-09T07:28:38+00:00\",\"dateModified\":\"2026-06-09T07:31:01+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/about-us\\\/manufacturing\\\/non-financial-information-statement\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/about-us\\\/manufacturing\\\/non-financial-information-statement\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/about-us\\\/manufacturing\\\/non-financial-information-statement\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"About Neuraxpharm\",\"item\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/about-us\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Manufacturing\",\"item\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/about-us\\\/manufacturing\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Non financial information statement\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/#website\",\"url\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/\",\"name\":\"Neuraxpharm\",\"description\":\"A European Leader for the CNS products\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.neuraxpharm.com\\\/uk\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Non financial information statement - Neuraxpharm","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/non-financial-information-statement","og_locale":"en_US","og_type":"article","og_title":"Non financial information statement","og_description":"This page is intended for members of the public in the UK seeking information on Neuraxpharm UK business (Estado de Informaci\u00f3n No Financiera \u2013 EINF, in Spanish) In order to comply with Law 11\/2018 on Non-Financial Information and Diversity, annually\u00a0 Neuraxpharm Pharmaceuticals S.L.U. (formerly Laboratorios Lesvi S.L.U.)\u00a0prepares its Non-Financial Information Statement, following the recommendations and [&hellip;]","og_url":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/non-financial-information-statement\/","og_site_name":"Neuraxpharm","article_modified_time":"2026-06-09T07:31:01+00:00","twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/non-financial-information-statement\/","url":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/non-financial-information-statement\/","name":"Non financial information statement - Neuraxpharm","isPartOf":{"@id":"https:\/\/www.neuraxpharm.com\/uk\/#website"},"datePublished":"2026-06-09T07:28:38+00:00","dateModified":"2026-06-09T07:31:01+00:00","breadcrumb":{"@id":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/non-financial-information-statement\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/non-financial-information-statement\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/non-financial-information-statement\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"About Neuraxpharm","item":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/"},{"@type":"ListItem","position":2,"name":"Manufacturing","item":"https:\/\/www.neuraxpharm.com\/uk\/about-us\/manufacturing\/"},{"@type":"ListItem","position":3,"name":"Non financial information statement"}]},{"@type":"WebSite","@id":"https:\/\/www.neuraxpharm.com\/uk\/#website","url":"https:\/\/www.neuraxpharm.com\/uk\/","name":"Neuraxpharm","description":"A European Leader for the CNS products","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.neuraxpharm.com\/uk\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"}]}},"acf":[],"_links":{"self":[{"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/pages\/21268","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/users\/2493"}],"replies":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/comments?post=21268"}],"version-history":[{"count":7,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/pages\/21268\/revisions"}],"predecessor-version":[{"id":21279,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/pages\/21268\/revisions\/21279"}],"up":[{"embeddable":true,"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/pages\/2412"}],"wp:attachment":[{"href":"https:\/\/www.neuraxpharm.com\/uk\/wp-json\/wp\/v2\/media?parent=21268"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}